3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Phase 2/3
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Vomiting
2
Nausea
2
Breast Neoplasms
2
Neoplasms
1
Interventions
Dexamethasone
12
Palonosetron
11
Aprepitant
11
Ondansetron
8
Olanzapine
5
Calcium Dobesilate
4
netupitant
2
fosaprepitant
2
Tropisetron
2
Radiotherapy
2
Fluorouracil
2
yangzheng xiaoji
1
rolapitant
1
ramosetron
1
niraparib
1
netupitant, palosentron drug combination
1
nabiximols
1
isatuximab
1
ginger extract
1
dolasetron
1
casopitant
1
Yoga
1
Therapeutics
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Paclitaxel
1
Oxaliplatin
1
Octreotide
1
Midazolam
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Nausea
×
netupitant
×
Clear all
NCT04669132
2022-02-23
OLNEPA
Instituto Brasileiro de Controle do Cancer
Phase 2
Completed
50 enrolled
NCT03862144
2019-03-05
GIM15-NEPA
Consorzio Oncotech
Phase 2
Completed
150 enrolled